Immunomedics is a biopharmaceutical company that specializes in the development and marketing of monoclonal, antibody-based products for cancer, autoimmune, and other serious diseases. The company operates primarily in the United States and Europe, and focuses on research, development, and manufacture of innovative therapies. With a strong commitment to meeting unmet medical needs, Immunomedics is dedicated to improving patient outcomes and advancing the field of biopharmaceuticals.
Mendus's ticker is IMMU
The company's shares trade on the NASDAQ stock exchange
They are based in Morris Plains, New Jersey
There are 51-200 employees working at Mendus
It is mendus.com/about-us
Mendus is in the Healthcare sector
Mendus is in the Biotechnology industry
The following five companies are Mendus's industry peers: